Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Phase III, Prospective, Open Label, Multicenter, Randomized Trial of Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone as First Line Therapy in Myeloma Patients Aged >65.

Authors not listed

Gruppo Italiano per lo Studio del Mieloma Multiplo · 2002

Abstract

The purpose of this study is to determine whether the association of Thalidomide to Melphalan and Prednisone is effective in the treatment of newly diagnosed elderly multiple myeloma.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Anonymous. (2002). Phase III, Prospective, Open Label, Multicenter, Randomized Trial of Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone as First Line Therapy in Myeloma Patients Aged >65. <em>Gruppo Italiano per lo Studio del Mieloma Multiplo</em>. https://clinicaltrials.gov/study/NCT00232934
Vancouver
Anonymous. Phase III, Prospective, Open Label, Multicenter, Randomized Trial of Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone as First Line Therapy in Myeloma Patients Aged >65. Gruppo Italiano per lo Studio del Mieloma Multiplo. 2002.
BibTeX
@misc{anon2002PhaseI, title = {Phase III, Prospective, Open Label, Multicenter, Randomized Trial of Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone as First Line Therapy in Myeloma Patients Aged >65.}, author = {Anonymous}, journal = {Gruppo Italiano per lo Studio del Mieloma Multiplo}, year = {2002}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings